Last modified: Mar 31, 2026, 12:29 AM
By Suchita Kumari
Carer Contributing Author

Non-Hodgkin’s lymphoma (NHL) is a type of cancer that originates in the lymphatic system, which is part of the body’s immune defense. In contrast to Hodgkin's lymphoma, NHL is more prevalent and encompasses a wide range of blood cancers that impact lymphocytes, which are white blood cells. The main features of NHL are examined in this article, along with its symptoms, causes, diagnosis, and available treatments.
NHL occurs when abnormal lymphocytes (a type of white blood cell) grow uncontrollably, forming tumors in lymph nodes or other lymphatic tissues. There are over 60 subtypes of NHL, classified based on the type of lymphocyte affected (B-cells or T-cells) and how quickly the cancer progresses (indolent or aggressive).
Depending on the subtype and stage, NHL symptoms can vary, however they frequently include:
Because these symptoms might mimic those of other conditions, it is important to see a specialist for a comprehensive evaluation.
The NHL subtype, stage, and general health of the patient all influence the course of treatment. Typical methods include of:
There are numerous subtypes and therapy options for non-Hodgkin's lymphoma, making it a complex disease. Better results can result from early symptom recognition and getting medical advice. Ongoing research continues to improve therapies, offering hope to patients worldwide.
Carer Circle is home to one of the largest databases of cancer related articles online.
Topics:
Further Reading